Genetic and Proteomic Analysis of Epstein-Barr Virus LMP1 Activation of NF-kB

EB 病毒 LMP1 激活 NF-kB 的遗传和蛋白质组学分析

基本信息

  • 批准号:
    8284169
  • 负责人:
  • 金额:
    $ 17.99万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2010
  • 资助国家:
    美国
  • 起止时间:
    2010-07-01 至 2015-06-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The Epstein Barr Virus (EBV) is an oncogenic gamma-herpesvirus that is associated with Hodgkin disease and anaplasmic nasopharyngeal carcinoma. EBV infection is particularly hazardous with advanced HIV disease or transplant, where EBV-encoded proteins drive aberrant cell growth in the absence of immune surveillance. The principal EBV oncogene, Latent Membrane Protein 1 (LMP1), promotes cell survival and proliferation by mimicking activated immune receptors. Through incompletely defined pathways, LMP1 potently stimulates Nuclear Factor Kappa B (NF-kB), transcription factors that control inflammation, cell survival and growth. EBV- transformed cells rely on constitutive NF-kB activation, and rapidly undergo apoptosis upon NF-kB blockade. Side-effects preclude the clinical use of currently available NF-kB inhibitors, though LMP1-selective drug targets may afford substantially less toxicity. It is therefore important to define how LMP1 activates NF-kB. I have carried out a human genome-wide siRNA screen for cellular modulators of LMP1 canonical NF-kB activation. Hits that either suppress or enhance LMP1 activation of NF-kB have been validated with secondary screens. The screens have implicated numerous proteins in LMP1 function, including novel factors not previously associated with NF-kB. I will carry out hypothesis-based and larger-scale secondary assays to identify critical missing components of LMP1 NF-kB activation in both epithelial cells and B lymphoblasts. I will pursue detailed biochemical analysis of several targets of particular interest, including potentially druggable enzymes and functionally clustered hits. Secondary screens will further stratify hits into functional groups based on whether they affect LMP1 expression, subcellular trafficking, and where they function within the LMP1/NF-kB pathway. Cellular factors uniquely employed by LMP1, but not by immune receptor pathways, may serve as important therapeutic targets for treatment of EBV-driven malignancies. Likewise, these studies may reveal important general mechanisms of NF-kB activation, with implications for allergy, autoimmunity, and host-defense. PUBLIC HEALTH RELEVANCE: Persistent Epstein Barr virus infection is an important cause of certain lymphoma and throat cancers. This project will better define how EBV subverts cellular machinery to drive cancerous growth of infected cells. Ultimately, it is hoped that knowledge gained from these studies may enable the development of chemotherapies that specifically block EBV function.
描述(由申请方提供):爱泼斯坦巴尔病毒(EBV)是一种致癌性γ-疱疹病毒,与霍奇金病和无浆性鼻咽癌相关。EBV感染对于晚期HIV疾病或移植特别危险,其中EBV编码的蛋白质在缺乏免疫监视的情况下驱动异常细胞生长。主要的EBV癌基因,潜伏膜蛋白1(LMP 1),通过模拟激活的免疫受体促进细胞存活和增殖。通过不完全确定的途径,LMP 1有效地刺激核因子κ B(NF-κ B),控制炎症,细胞存活和生长的转录因子。EBV转化的细胞依赖于组成性NF-kB活化,并且在NF-kB阻断后迅速经历细胞凋亡。副作用排除了目前可用的NF-κ B抑制剂的临床使用,尽管LMP 1选择性药物靶点可以提供实质上更少的毒性。因此,确定LMP 1如何激活NF-κ B是很重要的。我已经进行了人类全基因组siRNA筛选LMP 1典型NF-κ B激活的细胞调节剂。抑制或增强NF-κ B的LMP 1活化的命中已经用二次筛选验证。这些筛选涉及LMP 1功能中的许多蛋白质,包括以前与NF-kB无关的新因子。我将进行基于假设和更大规模的二次检测,以确定上皮细胞和B淋巴母细胞中LMP 1 NF-κ B激活的关键缺失成分。我将对几个特别感兴趣的目标进行详细的生化分析,包括潜在的药物酶和功能性聚集的命中。二次筛选将根据命中是否影响LMP 1表达、亚细胞运输以及它们在LMP 1/NF-kB通路中的功能进一步将命中分层为功能组。LMP 1独特使用的细胞因子,而不是免疫受体途径,可能作为治疗EBV驱动的恶性肿瘤的重要治疗靶点。同样地,这些研究可能揭示NF-κ B活化的重要一般机制,涉及过敏、自身免疫和宿主防御。 公共卫生相关性:持续性爱泼斯坦巴尔病毒感染是某些淋巴瘤和喉癌的重要原因。该项目将更好地定义EBV如何颠覆细胞机制以驱动受感染细胞的癌性生长。最终,希望从这些研究中获得的知识可以开发特异性阻断EBV功能的化疗药物。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Benjamin Elison Gewurz其他文献

Benjamin Elison Gewurz的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Benjamin Elison Gewurz', 18)}}的其他基金

Characterization of Epstein-Barr Virus Subversion of the Host SMC5/6 Restriction Pathway
Epstein-Barr 病毒颠覆宿主 SMC5/6 限制途径的特征
  • 批准号:
    10679118
  • 财政年份:
    2023
  • 资助金额:
    $ 17.99万
  • 项目类别:
Methionine and PI3K Metabolism Drive CIMP in EBV Epithelial Cancers
蛋氨酸和 PI3K 代谢驱动 EBV 上皮癌中的 CIMP
  • 批准号:
    10627692
  • 财政年份:
    2023
  • 资助金额:
    $ 17.99万
  • 项目类别:
Regulation of the Epstein-Barr Virus Lytic Switch
Epstein-Barr 病毒裂解开关的调节
  • 批准号:
    10643950
  • 财政年份:
    2021
  • 资助金额:
    $ 17.99万
  • 项目类别:
Regulation of the Epstein-Barr Virus Lytic Switch
Epstein-Barr 病毒裂解开关的调节
  • 批准号:
    10317642
  • 财政年份:
    2021
  • 资助金额:
    $ 17.99万
  • 项目类别:
Regulation of the Epstein-Barr Virus Lytic Switch
Epstein-Barr 病毒裂解开关的调节
  • 批准号:
    10445326
  • 财政年份:
    2021
  • 资助金额:
    $ 17.99万
  • 项目类别:
Epstein-Barr virus LMP1 mediated oncogenicity
EB 病毒 LMP1 介导的致癌性
  • 批准号:
    10676959
  • 财政年份:
    2019
  • 资助金额:
    $ 17.99万
  • 项目类别:
Epstein-Barr virus LMP1 mediated oncogenicity
EB 病毒 LMP1 介导的致癌性
  • 批准号:
    10020965
  • 财政年份:
    2019
  • 资助金额:
    $ 17.99万
  • 项目类别:
Metabolic Network Remodeling in Epstein-Barr Virus Lymphomagenesis
EB 病毒淋巴瘤发生中的代谢网络重塑
  • 批准号:
    9899193
  • 财政年份:
    2018
  • 资助金额:
    $ 17.99万
  • 项目类别:
Metabolic Network Remodeling in Epstein-Barr Virus Lymphomagenesis
EB 病毒淋巴瘤发生中的代谢网络重塑
  • 批准号:
    10353408
  • 财政年份:
    2018
  • 资助金额:
    $ 17.99万
  • 项目类别:
Genetic and Proteomic Analysis of Epstein-Barr Virus LMP1 Activation of NF-kB
EB 病毒 LMP1 激活 NF-kB 的遗传和蛋白质组学分析
  • 批准号:
    8068346
  • 财政年份:
    2010
  • 资助金额:
    $ 17.99万
  • 项目类别:

相似海外基金

RII Track-4:NSF: From the Ground Up to the Air Above Coastal Dunes: How Groundwater and Evaporation Affect the Mechanism of Wind Erosion
RII Track-4:NSF:从地面到沿海沙丘上方的空气:地下水和蒸发如何影响风蚀机制
  • 批准号:
    2327346
  • 财政年份:
    2024
  • 资助金额:
    $ 17.99万
  • 项目类别:
    Standard Grant
BRC-BIO: Establishing Astrangia poculata as a study system to understand how multi-partner symbiotic interactions affect pathogen response in cnidarians
BRC-BIO:建立 Astrangia poculata 作为研究系统,以了解多伙伴共生相互作用如何影响刺胞动物的病原体反应
  • 批准号:
    2312555
  • 财政年份:
    2024
  • 资助金额:
    $ 17.99万
  • 项目类别:
    Standard Grant
How Does Particle Material Properties Insoluble and Partially Soluble Affect Sensory Perception Of Fat based Products
不溶性和部分可溶的颗粒材料特性如何影响脂肪基产品的感官知觉
  • 批准号:
    BB/Z514391/1
  • 财政年份:
    2024
  • 资助金额:
    $ 17.99万
  • 项目类别:
    Training Grant
Graduating in Austerity: Do Welfare Cuts Affect the Career Path of University Students?
紧缩毕业:福利削减会影响大学生的职业道路吗?
  • 批准号:
    ES/Z502595/1
  • 财政年份:
    2024
  • 资助金额:
    $ 17.99万
  • 项目类别:
    Fellowship
感性個人差指標 Affect-X の構築とビスポークAIサービスの基盤確立
建立个人敏感度指数 Affect-X 并为定制人工智能服务奠定基础
  • 批准号:
    23K24936
  • 财政年份:
    2024
  • 资助金额:
    $ 17.99万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Insecure lives and the policy disconnect: How multiple insecurities affect Levelling Up and what joined-up policy can do to help
不安全的生活和政策脱节:多种不安全因素如何影响升级以及联合政策可以提供哪些帮助
  • 批准号:
    ES/Z000149/1
  • 财政年份:
    2024
  • 资助金额:
    $ 17.99万
  • 项目类别:
    Research Grant
How does metal binding affect the function of proteins targeted by a devastating pathogen of cereal crops?
金属结合如何影响谷类作物毁灭性病原体靶向的蛋白质的功能?
  • 批准号:
    2901648
  • 财政年份:
    2024
  • 资助金额:
    $ 17.99万
  • 项目类别:
    Studentship
ERI: Developing a Trust-supporting Design Framework with Affect for Human-AI Collaboration
ERI:开发一个支持信任的设计框架,影响人类与人工智能的协作
  • 批准号:
    2301846
  • 财政年份:
    2023
  • 资助金额:
    $ 17.99万
  • 项目类别:
    Standard Grant
Investigating how double-negative T cells affect anti-leukemic and GvHD-inducing activities of conventional T cells
研究双阴性 T 细胞如何影响传统 T 细胞的抗白血病和 GvHD 诱导活性
  • 批准号:
    488039
  • 财政年份:
    2023
  • 资助金额:
    $ 17.99万
  • 项目类别:
    Operating Grants
How motor impairments due to neurodegenerative diseases affect masticatory movements
神经退行性疾病引起的运动障碍如何影响咀嚼运动
  • 批准号:
    23K16076
  • 财政年份:
    2023
  • 资助金额:
    $ 17.99万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了